You are here: Home » News-CM » Equities » Stock Alert
Business Standard

HDFC Bank, HCL Tech, Avenue Supermarts to react to earnings

Capital Market 

HDFC Bank reported an 17.6% increase in its net profit to Rs 8834.30 crore in Q2FY22 over Q2FY21. The bank's net revenues rose 14.7% to Rs 25085.20 crore in Q2FY22 over Q2FY21.

HCL Technologies reported 1.6% increase in consolidated profit to Rs 3,265 crore on 2.9% rise in revenue to Rs 20,655 crore in Q2FY22 over Q1FY22.

Avenue Supermarts' reported consolidated net profit of Rs 418 crore in Q2FY22 as compared to net profit of Rs 199 crore in Q2FY21. The company's total revenue rose to Rs 7789 crore in Q2FY22 from Rs 5306 crore in Q2FY21.

Dr. Reddy's Laboratories along with its subsidiaries announced the launch of Carmustine for Injection, USP, a therapeutic equivalent generic version of BiCNU (carmustine for injection) approved by the U.S. Food and Drug Administration (USFDA).

Lupin Pharmaceuticals Inc. is voluntarily recalling select batches of Irbesartan Tablets and Irbesartan and Hydrochlorothiazide Tablets to the consumer level. Lupin Pharmaceuticals, Inc. is the U.S. based wholly-owned subsidiary of Lupin.

IndusInd Bank has scheduled a meeting of the board of directors of the bank on 21 October 2021 to consider and approve, the proposal relating to raising of funds in Indian or Foreign Currency through the issuance of Unsecured Non-Convertible Redeemable Basel III-Compliant Regulatory Tier II Bonds, subject to receipt of regulatory / statutory approvals.

PNB Housing Finance said that its board has decided not to proceed with a preferential issue of shares to investors led by Carlyle after the plan was delayed due to pending legal proceedings.

NBCC (India) secured the total business of Rs. 2100.96 crore in September 2021.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Mon, October 18 2021. 08:52 IST